BEL 20 Stock

Index

Market Closed - Euronext Bruxelles 19:05:02 13/10/2026 +03			5-day change	1st Jan Change
5,496.41 ^PTS	+0.11%		-1.32%	+8.23%

07-30	AB InBev Slips on Profit-Taking After Q2
06-18	BlackRock Crosses Above the 3% Threshold in AB InBev

07-30	AB InBev Slips on Profit-Taking After Q2
06-18	BlackRock Crosses Above the 3% Threshold in AB InBev
05-04	Gimv Takes a Minority Stake in Azelis, Which Rises on the Stock Market
30/10/25	AB InBev's cash redistributions overshadow a mixed Q3
01/10/25	Pharmaceutical companies are booming in stockmarket thanks to Trump
22/09/25	Warehouses De Pauw SA(ENXTBR:WDP) added to Amsterdam AEX Index	CI
19/09/25	Warehouses De Pauw SA(ENXTBR:WDP) dropped from AMX Index	CI
14/08/25	Belgium's top index breaks 18-year-old record, capping slow recovery from 2008 crisis	RE
14/08/25	Belgium's top index breaks 18-year-old record, capping slow recovery from 2008 crisis	RE
08/08/25	Bpost: 2025 EBIT expected at top of range after solid Q2
07/08/25	KBC: 2025 forecasts raised after better-than-expected Q2
01/08/25	Umicore: EBITDA up but cash flow concerns
18/07/25	Joy in the Air

10-08	Anheuser-Busch InBev Seeing Growth in Emerging Markets, Benefiting From Currency Tailwind, RBC Says	MT
10-08	Wedbush Adjusts argenx SE Price Target to $1,130 From $1,150, Maintains Outperform Rating	MT
10-08	AB InBev outperforms in Brussels, as RBC still very bullish
10-08	RBC Raises Price Target on Anheuser-Busch InBev to EUR95 From EUR93, Keeps Outperform Rating	MT
10-08	AB InBev Price Target Up as RBC Says Shares 'Meaningfully Undervalued'	MT
10-08	Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble	RE
10-08	Argenx Shares Plunge After Autoimmune-Disease Trial Halt	DJ
10-08	Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell	MT
10-08	Argenx to Discontinue Late-stage Study of Subcutaneous Efgartigimod in Sjögren's Disease	MT
10-08	Argenx's Celiac Drug Meets Primary Endpoint in Mid-stage Trial	MT

No results match your criteria

07-06	Partir au sommet
06-30	IBA soutenu par une bonne dynamique commerciale
06-18	BlackRock franchit à la hausse le seuil de 3% chez AB InBev
06-08	Chemie onder druk in lichtrode Bel20
06-08	Rode koersen in Brussel

	Name	Change	AuM	5-day change
	AMUNDI BEL 20 UCITS ETF - DIST - EUR	+0.24%	85 M€	-1.35%
	MULTI UNITS FRANCE - LYXOR UCITS ETF BEL 20 TR	-0.37%	85 M€	+1.32%

Date	Price	Change	Volume
13/10/26	PTS 5,496.41	+0.11%	4,499,547
12/10/26	PTS 5,490.22	+0.65%	4,605,210
09/10/26	PTS 5,454.74	+1.02%	4,368,000
08/10/26	PTS 5,399.40	-2.32%	5,650,656
07/10/26	PTS 5,527.87	-0.76%	4,888,995